• 1
    NIH data book 1990, table 44. In: National Institutes of Health Publication 90–126. Bethesda , MD : Department of Health and Human Services, 1990;76.
  • 2
    Rachelefsky GS, Goldberg M, Katz RM, et al. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978;61:31014.
  • 3
    Savolainen S. Allergy in patients with acute maxillary sinusitis. Allergy 1989;44:11622.
  • 4
    Demoly P, Crampette L, Mondain M, et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol 1994;94:95108.
  • 5
    Goldenhersh MJ, Rachelefsky GS, Dudley J, et al. The microbiology of chronic sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1990;85: 10309.
  • 6
    Ylikoski J, Savolainen S, Jousimies-Somer H. The bacteriology of acute maxillary sinusitis. ORL J Otorhinolaryngol Relat Spec 1989;51:17581.
  • 7
    Dohlman A. Role of antibiotic and non-antibiotic therapy in the treatment of sinusitis with an allergic basis. Clin Exp Allergy 1994;24: 10947.
  • 8
    Dohlman AW, Hemstreet MP, Odrezin GT, Bartolucci AA. Subacute sinusitis: are antimicrobials necessary J Allergy Clin Immunol 1993;91: 101523.
  • 9
    Rachelefsky GS, Katz RM, Siegel SC. Chronic sinusitis in children with respiratory allergy: the role of antimicrobials. J Allergy Clin Immunol 1982;69:3827.
  • 10
    Otten FW, Grote JJ. Treatment of chronic maxillary sinusitis in children. Int J Pediatr Otorhinolaryngol 1988;15: 26978.
  • 11
    Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:81223.
  • 12
    Cuenant G, Stipon JP, Plante-Longchamp G, Baudoin C, Guerrier Y. Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec 1986;48:22632.
  • 13
    Clissold SP, Sorkin EM, Goa KL. Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989;37:4257.
  • 14
    Bruttmann G, Charpin D, Germouty J, Horak F, Kunkel G, Wittmann G. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis. J Allergy Clin Immunol 1989;83:41116.
  • 15
    Frolund L, Etholm B, Irander K, et al. A multicentre study of loratadine, clemastine and placebo in patients with perennial allergic rhinitis. Allergy 1990;45:25461.
  • 16
    Druce HM. Emerging techniques in the diagnosis of sinusitis. Ann Allergy 1991;66:1326.
  • 17
    Bull T. Examination of the nose: conditions of the external nose. In: MackayI, BullT, editors. Scott-Brown's Otolaryngology. Rhinology. 5th ed. London : Butterworths, 1987; 19.
  • 18
    Lund VJ, Scadding GK. Objective assessment of endoscopic sinus surgery in the management of chronic rhinosinusitis: an update. J Laryngol Otol 1994;108:74953.
  • 19
    International Consensus Report on the Diagnosis and Management of Rhinitis. International Rhinitis Management Working Group. Allergy 1994;49 Suppl 19:134.
  • 20
    Lund VJ, Kennedy DW. Quantification for staging sinusitis. Ann Otol Rhinol Laryngol Suppl 1995;167:1721.
  • 21
    Bousquet J, Michel F. In vivo methods for study of allergy. Skin tests, techniques and interpretation. In: MiddletonE, ReedC, EllisE, AdkinsonN, YungingerJ, BusseW, editors. Allergy, principles and practice. 4th ed. St Louis , MO : Mosby, 1993;57394.
  • 22
    Dreborg S, Backman A, Basomba A, Bousquet J, Dieges P, Mailing H. Skin tests used in type I allergy testing. Position Paper of the European Academy of Allergology and Clinical Immunology. Allergy 1988;44 Suppl 10:169.
  • 23
    Gwaltney JM, Jones JG, Kennedy DW. Medical management of sinusitis: educational goals and management guidelines. Ann Otol Rhinol Laryngol Suppl 1995;167:2230.
  • 24
    Derebery MJ. Otolaryngic allergy. Otolaryngol Clin North Am 1993;26:593611.
  • 25
    Wald ER, Byers C, Guerra N, Casselbrant M, Beste D. Subacute sinusitis in children. J Pediatr 1989;115:2832.
  • 26
    Brook I, Thompson DH, Frazier EH. Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1994;120: 131720.
  • 27
    Legent F, Bordure P, Beauvillain C, Berche P. A double-blind comparison of ciprofloxacin and amoxicillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994;1:815.
  • 28
    Druce HM. Adjuncts to medical management of sinusitis. Otolaryngol Head Neck Surg 1990;103:8803.
  • 29
    Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989;83:62733.
  • 30
    Mygind N. Pharmacological management of perennial rhinitis. Rhinol Suppl 1991;11:216.
  • 31
    Berman BA. Perennial allergic rhinitis: clinical efficacy of a new antihistamine. J Allergy Clin Immunol 1990;86: 10048.
  • 32
    Lockey R, Fox R. Loratadine (SCH29851) 10 mg OD vs clemastine 1 mg BID in the treatment of perennial allergic rhinitis. Immunol Allergy Pract 1989;11:4239.
  • 33
    Bousquet J, Duchateau J, Pignat J, et al. Improvement of quality of life by cetirizine in perennial allergic rhinitis using a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98:30916.
  • 34
    Brooks CD, Karl KJ, Francom SF. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990;20: 216.
  • 35
    Ciprandi G, Buscaglia S, Pronzato C, et al. New targets for antiallergic agents. In: LangerS, ChurchM, VargaftigB, NicosiaS, editors. New targets for antiallergic agents. Basel : Karger, 1993;11527.
  • 36
    Ciprandi G, Buscaglia S, Catrullo A, Marchesi E, Bianchi B, Canonica GW. Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. Ann Allergy 1995;75:11520.